1327 related articles for article (PubMed ID: 29771327)
1. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies.
Brouwer TF; Knops RE; Kutyifa V; Barr C; Mondésert B; Boersma LVA; Lambiase PD; Wold N; Jones PW; Healey JS
Europace; 2018 Sep; 20(FI2):f240-f248. PubMed ID: 29771327
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy.
Brouwer TF; Yilmaz D; Lindeboom R; Buiten MS; Olde Nordkamp LR; Schalij MJ; Wilde AA; van Erven L; Knops RE
J Am Coll Cardiol; 2016 Nov; 68(19):2047-2055. PubMed ID: 27810043
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and early clinical outcomes of patients undergoing totally subcutaneous vs. transvenous single chamber implantable cardioverter defibrillator placement.
Mithani AA; Kath H; Hunter K; Andriulli J; Ortman M; Field J; Russo AM
Europace; 2018 Feb; 20(2):308-314. PubMed ID: 28383717
[TBL] [Abstract][Full Text] [Related]
4. A propensity matched case-control study comparing efficacy, safety and costs of the subcutaneous vs. transvenous implantable cardioverter defibrillator.
Honarbakhsh S; Providencia R; Srinivasan N; Ahsan S; Lowe M; Rowland E; Hunter RJ; Finlay M; Segal O; Earley MJ; Chow A; Schilling RJ; Lambiase PD
Int J Cardiol; 2017 Feb; 228():280-285. PubMed ID: 27865198
[TBL] [Abstract][Full Text] [Related]
5. Transvenous and non-transvenous implantable cardioverter-defibrillators in children, adolescents, and adults with congenital heart disease: who is at risk for appropriate and inappropriate shocks?
Krause U; Müller MJ; Wilberg Y; Pietzka M; Backhoff D; Ruschewski W; Paul T
Europace; 2019 Jan; 21(1):106-113. PubMed ID: 30339209
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Systematic Review and Meta-Analysis of Randomized Trials and Propensity Score-Matched Studies.
Fong KY; Ng CJR; Wang Y; Yeo C; Tan VH
J Am Heart Assoc; 2022 Jun; 11(11):e024756. PubMed ID: 35656975
[TBL] [Abstract][Full Text] [Related]
7. Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis.
Nakhoul GN; Schold JD; Arrigain S; Harb SC; Jolly S; Wilkoff BL; Nally JV; Navaneethan SD
Clin J Am Soc Nephrol; 2015 Jul; 10(7):1119-27. PubMed ID: 26111859
[TBL] [Abstract][Full Text] [Related]
8. Peri-procedural routines, implantation techniques, and procedure-related complications in patients undergoing implantation of subcutaneous or transvenous automatic cardioverter-defibrillators: results of the European Snapshot Survey on S-ICD Implantation (ESSS-SICDI).
Lenarczyk R; Boveda S; Haugaa KH; Potpara TS; Syska P; Jedrzejczyk-Patej E; Chauvin M; Sadoul N; Dagres N
Europace; 2018 Jul; 20(7):1218-1224. PubMed ID: 29762683
[TBL] [Abstract][Full Text] [Related]
9. Dual- vs. single-chamber defibrillators for primary prevention of sudden cardiac death: long-term follow-up of the Défibrillateur Automatique Implantable-Prévention Primaire registry.
Defaye P; Boveda S; Klug D; Beganton F; Piot O; Narayanan K; Périer MC; Gras D; Fauchier L; Bordachar P; Algalarrondo V; Babuty D; Deharo JC; Leclercq C; Marijon E; Sadoul N;
Europace; 2017 Sep; 19(9):1478-1484. PubMed ID: 28340096
[TBL] [Abstract][Full Text] [Related]
10. Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry.
Almehmadi F; Porta-Sánchez A; Ha ACT; Fischer HD; Wang X; Austin PC; Lee DS; Nanthakumar K
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862957
[TBL] [Abstract][Full Text] [Related]
11. Low Prevalence of Inappropriate Shocks in Patients With Inherited Arrhythmia Syndromes With the Subcutaneous Implantable Defibrillator Single Center Experience and Long-Term Follow-Up.
Rudic B; Tülümen E; Berlin V; Röger S; Stach K; Liebe V; El-Battrawy I; Dösch C; Papavassiliu T; Akin I; Borggrefe M; Kuschyk J
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042423
[TBL] [Abstract][Full Text] [Related]
12. Intensive recreational athletes in the prospective multinational ICD Sports Safety Registry: Results from the European cohort.
Heidbuchel H; Willems R; Jordaens L; Olshansky B; Carre F; Lozano IF; Wilhelm M; Müssigbrodt A; Huybrechts W; Morgan J; Anfinsen OG; Prior D; Mont L; Mairesse GH; Boveda S; Duru F; Kautzner J; Viskin S; Geelen P; Cygankiewicz I; Hoffmann E; Vandenberghe K; Cannom D; Lampert R
Eur J Prev Cardiol; 2019 May; 26(7):764-775. PubMed ID: 30813818
[TBL] [Abstract][Full Text] [Related]
13. Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies.
Basu-Ray I; Liu J; Jia X; Gold M; Ellenbogen K; DiNicolantonio J; Komócsi A; Vorobcsuk A; Kim J; Afshar H; Lam W; Mathuria N; Razavi M; Rasekh A; Saeed M
JACC Clin Electrophysiol; 2017 Dec; 3(13):1475-1483. PubMed ID: 29759827
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial.
Knops RE; van der Stuijt W; Delnoy PPHM; Boersma LVA; Kuschyk J; El-Chami MF; Bonnemeier H; Behr ER; Brouwer TF; Kääb S; Mittal S; Quast ABE; Smeding L; Tijssen JGP; Bijsterveld NR; Richter S; Brouwer MA; de Groot JR; Kooiman KM; Lambiase PD; Neuzil P; Vernooy K; Alings M; Betts TR; Bracke FALE; Burke MC; de Jong JSSG; Wright DJ; Jansen WPJ; Whinnet ZI; Nordbeck P; Knaut M; Philbert BT; van Opstal JM; Chicos AB; Allaart CP; Borger van der Burg AE; Clancy JF; Dizon JM; Miller MA; Nemirovsky D; Surber R; Upadhyay GA; Weiss R; de Weger A; Wilde AAM; Olde Nordkamp LRA;
Circulation; 2022 Feb; 145(5):321-329. PubMed ID: 34779221
[TBL] [Abstract][Full Text] [Related]
15. Prevention of Sudden Cardiac Death: Focus on the Subcutaneous Implantable Cardioverter-Defibrillator.
Adduci C; Palano F; Silvetti G; Cosentino P; Francia P
High Blood Press Cardiovasc Prev; 2020 Aug; 27(4):291-297. PubMed ID: 32519207
[TBL] [Abstract][Full Text] [Related]
16. Multicentre experience with the second-generation subcutaneous implantable cardioverter defibrillator and the intermuscular two-incision implantation technique.
Migliore F; Mattesi G; De Franceschi P; Allocca G; Crosato M; Calzolari V; Fantinel M; Ortis B; Facchin D; Daleffe E; Fabris T; Marras E; De Lazzari M; Zanon F; Marcantoni L; Siciliano M; Corrado D; Iliceto S; Bertaglia E; Zecchin M
J Cardiovasc Electrophysiol; 2019 Jun; 30(6):854-864. PubMed ID: 30827041
[TBL] [Abstract][Full Text] [Related]
17. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM
Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943
[TBL] [Abstract][Full Text] [Related]
18. Sex differences among subcutaneous implantable cardioverter-defibrillator recipients: a propensity-matched, multicentre, international analysis from the i-SUSI project.
Schiavone M; Gasperetti A; Vogler J; Compagnucci P; Laredo M; Breitenstein A; Gulletta S; Martinek M; Kaiser L; Tundo F; Palmisano P; Rovaris G; Curnis A; Kuschyk J; Biffi M; Tilz R; Di Biase L; Tondo C; Forleo GB;
Europace; 2024 May; 26(5):. PubMed ID: 38696701
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms and management of inappropriate therapy in subcutaneous implantable cardioverter defibrillators.
Karnik AA; Helm RH; Monahan KM
J Cardiovasc Electrophysiol; 2019 Mar; 30(3):402-409. PubMed ID: 30576031
[TBL] [Abstract][Full Text] [Related]
20. Eligibility of Pacemaker Patients for Subcutaneous Implantable Cardioverter Defibrillators.
Ip JE; Wu MS; Kennel PJ; Thomas G; Liu CF; Cheung JW; Markowitz SM; Lerman BB
J Cardiovasc Electrophysiol; 2017 May; 28(5):544-548. PubMed ID: 28185354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
